Validation of Preoperative Risk Grouping of the Selection of Patients Most Likely to Benefit From Neoadjuvant Chemotherapy Before Radical Cystectomy-Reference-Cited by-同舟云学术

Validation of Preoperative Risk Grouping of the Selection of Patients Most Likely to Benefit From Neoadjuvant Chemotherapy Before Radical Cystectomy

Published:2017-04 Issue:2 Volume:15 Page:e267-e273
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Moschini Marco^ORCID,Soria Francesco,Klatte Tobias,Wirth Gregory J.,Özsoy Mehmet,Gust Killian,Briganti Alberto,Roupret Morgan,Susani Martin,Haitel Andrea,Shariat Shahrokh F.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference24 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

2. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines;Witjes;Eur Urol,2014

3. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients;Stein;J Clin Oncol,2001

4. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium;Shariat;J Urol,2006

5. Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: a 20-year single center experience;Moschini;Eur J Surg Oncol,2016

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of response to neoadjuvant therapy in urothelial cancer;Critical Reviews in Oncology/Hematology;2024-02

2. Predictive and Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Muscle Invasive Bladder Cancer Treated With Neoadjuvant Chemotherapy and Radical Cystectomy;Clinical Genitourinary Cancer;2023-08

3. Evaluation of short-term outcomes of neoadjuvant chemotherapy followed by radical cystectomy in muscle-invasive bladder cancer: a single Egyptian institution experience;Journal of the Egyptian National Cancer Institute;2023-05-05

4. Nomogram based on baseline clinicopathological characteristics for predicting bladder cancer-specific survival to neoadjuvant chemotherapy in muscle-invasive bladder cancer;World Journal of Urology;2022-09-15

5. Molecular biomarkers to help select neoadjuvant systemic therapy for urothelial carcinoma of the bladder;Current Opinion in Urology;2022-07-15